港股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

迈威生物-B

25.560

+1.0604.33%

成交量：229.84万

成交额：5,848.48万

市值：114.25亿

市盈率：-9.08

高：26.300

开：24.720

低：24.440

收：24.500

52周最高：31.460

52周最低：20.800

股本：4.47亿

香港流通股本：4,713.02万

量比：1.03

换手率：4.88%

股息：- -

股息率：- -

每股收益(LYR):-2.814

净资产收益率：-118.88%

总资产收益率：-11.80%

市净率：92.37

市盈率(LYR):-9.08

市销率: 13.24

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

港股异动 | 迈威生物-B(02493)再涨超7% 全球首个清除型抗体获批临床用于治疗炎症性肠病

港股异动 | 迈威生物-B(02493)逆市涨超7% 9MW5211注射液临床试验申请获国家药监局批准

迈威生物－Ｂ(02493)股价上升5.066%，现价港币$22.4

阿斯达克财经

迈威生物-B 2026年5月无新增发行或股份变动

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/02493"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02493","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02493\",,,,,undefined,":{"symbol":"02493","market":"HK","secType":"STK","nameCN":"迈威生物-B","latestPrice":25.56,"timestamp":1781165308202,"preClose":24.5,"halted":0,"volume":2298400,"delay":0,"changeRate":0.04326530612244893,"floatShares":47130200,"shares":447000000,"eps":-2.8139217207334273,"marketStatus":"未开盘","change":1.06,"latestTime":"06-11 16:08:28","open":24.72,"high":26.3,"low":24.44,"amount":58484776,"amplitude":0.075918,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.6992804654442875,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781227800000},"marketStatusCode":0,"adr":0,"listingDate":1777305600000,"exchange":"SEHK","adjPreClose":24.5,"openAndCloseTimeList":[[1781141400000,1781150400000],[1781154000000,1781164800000]],"volumeRatio":1.031394159119577,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688062","market":"SH","secType":"STK","nameCN":"迈威生物-U","latestPrice":27.23,"timestamp":1781161200000,"preClose":27.27,"halted":0,"volume":9444400,"delay":0,"premium":"-18.94"}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02493\",,,,,undefined,":{"symbol":"02493","floatShares":47130200,"roa":"-11.80%","roe":"-118.88%","lyrEps":-2.813944,"volumeRatio":1.031394159119577,"shares":447000000,"dividePrice":0,"high":26.3,"amplitude":0.075918,"preClose":24.5,"low":24.44,"week52Low":20.8,"pbRate":"92.37","psRate":"13.24","week52High":31.46,"institutionHeld":0,"latestPrice":25.56,"eps":-2.8139437701282723,"divideRate":0,"volume":2298400,"delay":0,"ttmEps":-2.6993016165304535,"open":24.72,"prevYearClose":27.64,"fiveDayClose":22.66,"twentyDayClose":25.14,"sixtyDayClose":27.64},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02493\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02493\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02493\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":1,"buy":0,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":1,"analysts":1,"updateTime":1772035200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02493\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02493","date":"2026-06-10","current":-9.486412,"percent":0.848485,"low":-17.302507,"twenty":-16.539919,"median":-15.54815,"eighty":-13.471899,"high":-12.171256,"avg":-15.124711,"sd":1.470531,"marketCap":13722005186.81},"quantilePoints":[{"date":"2026-04-24","current":-15.289641,"twenty":-16.199622,"median":-15.659552,"eighty":-15.437605,"marketCap":17000217748.15},{"date":"2026-04-30","current":-16.640195,"twenty":-16.379645,"median":-15.593679,"eighty":-15.250239,"marketCap":17562577595.07},{"date":"2026-05-08","current":-16.416983,"twenty":-16.631559,"median":-16.471868,"eighty":-15.350449,"marketCap":17380742435.69},{"date":"2026-05-15","current":-16.009725,"twenty":-16.685787,"median":-16.416983,"eighty":-15.606854,"marketCap":16994157190.87},{"date":"2026-05-22","current":-15.517615,"twenty":-16.631559,"median":-16.0746,"eighty":-15.529829,"marketCap":16434142933.1},{"date":"2026-05-29","current":-14.179755,"twenty":-16.597014,"median":-15.628209,"eighty":-15.240388,"marketCap":15069483633.31},{"date":"2026-06-05","current":-12.517432,"twenty":-16.559668,"median":-15.581594,"eighty":-14.26556,"marketCap":13322161865.15},{"date":"2026-06-10","current":-12.90069,"twenty":-16.539919,"median":-15.54815,"eighty":-13.471899,"marketCap":13722005186.81}],"updateTime":1781186186275},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02493\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2642018724","title":"港股异动 | 迈威生物-B(02493)再涨超7% 全球首个清除型抗体获批临床 用于治疗炎症性肠病","url":"https://stock-news.laohu8.com/highlight/detail?id=2642018724","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642018724?lang=zh_cn&edition=fundamental","pubTime":"2026-06-11 14:39","pubTimestamp":1781159980,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，迈威生物-B再涨超7%，截至发稿，涨5.71%，报25.9港元，成交额4853.7万港元。消息面上，6月4日，迈威生宣布其自主研发的抗体创新药9MW5211注射液正式获得中国国家药品监督管理局批准，可针对炎症性肠病开展临床试验。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1453051.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02493","VXUS","BK1161","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642411530","title":"港股异动 | 迈威生物-B(02493)逆市涨超7% 9MW5211注射液临床试验申请获国家药监局批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2642411530","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642411530?lang=zh_cn&edition=fundamental","pubTime":"2026-06-10 10:09","pubTimestamp":1781057355,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，迈威生物-B逆市涨超7%。截至发稿，涨6.54%，报23.78港元，成交额860.25万港元。消息面上，迈威生物近期宣布，公司自主研发的抗体创新药9MW5211正式获得国家药品监督管理局批准，可针对炎症性肠病开展临床试验。9MW5211在其靶点上是全球首款进入临床阶段的候选药物。此前，9MW5211已获FDA许可在美国开展针对IBD的临床试验。两项研究均展现出令人鼓舞的疗效及良好的安全性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452372.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","VXUS","02493","BK4585","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642452940","title":"迈威生物－Ｂ(02493)股价上升5.066%，现价港币$22.4","url":"https://stock-news.laohu8.com/highlight/detail?id=2642452940","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642452940?lang=zh_cn&edition=fundamental","pubTime":"2026-06-09 14:15","pubTimestamp":1780985700,"startTime":"0","endTime":"0","summary":"[上升股]迈威生物－Ｂ(02493) 股价在下午02:14比前收市价上升5.066%，现股价为港币$22.4。至目前为止，今日最高价为$22.4，而最低价为$20.94。总成交量为76.32万股，总成交金额为港币$1.663千万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2606093929/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2606093929/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171924678","title":"迈威生物-B 2026年5月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1171924678","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171924678?lang=zh_cn&edition=fundamental","pubTime":"2026-06-05 08:05","pubTimestamp":1780617939,"startTime":"0","endTime":"0","summary":"迈威（上海）生物科技股份有限公司于2026年6月5日发布2026年5月股份变动月报表，报告期为2026年5月1日至2026年5月31日。公告显示，公司本期无新发行股份或其他股本变动情况，股本结构保持稳定。最后，公司声明已严格遵守适用的香港联交所《上市规则》及其他相关法律法规进行相关证券发行或股份变动事宜，并及时向监管机构递交报告。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02493"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":12,"pageCount":1,"totalSize":47,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/02493\",params:#limit:6,delay:false,,,undefined,":[]}}